Accelerating discovery: COVID-19 vaccine breakthroughs and their future impact

While some vaccines can take almost 15 years to be approved, the rate at which COVID-19 vaccines have been developed (1 year) is truly remarkable. The collaboration across disciplines, continents, and companies was unheard of and several emerging technologies emerged as key players.  From mRNA to lipid nanoparticles to cross protection of vaccines – this vaccine rush has re-shaped the landscape ahead.

Accelerating Covid Vaccine Breakthroughs white paper cover image

Download the insights report

Related CAS Insights

創薬

A review of the global efforts on COVID-19 vaccine development

March 29, 2021

Read article
創薬

ACE2という、疾病病因特定において潜在的に重要なレセプターを標的にする

December 15, 2022

Read article
創薬

ACS webinar on molecular glues and targeted protein degradation

October 12, 2022

Read article

Gain new perspectives for faster progress directly to your inbox.